Vilazodone Hydrochloride Tablet
Product Images NDC 16729-352

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vilazodone Hydrochloride (NDC 16729-352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vilazodone Hydrochloride 10 mg-30 Tablets (Label)

This is a medication description for Vilazodone Hydrochloride tablets, containing 10mg of the drug. The usual dosage is unknown and should be referred to the package insert. The medication should be stored in a tightly closed container and kept out of children's reach at room temperature. It indicates that it is manufactured by Intas Pharmaceuticals Limited, INDIA, and is licensed for sale in the US by Accord Healthcare, Inc., Durham. A medication guide is enclosed and should be given to each patient.*

FDA Label Image

Vilazodone Hydrochloride 20 mg-30 Tablets (Label)

Each tablet is film-coated and contains 20 mg of Vilazodone Hydrochloride under NDG 16729-393-10. The typical dosage must be reviewed in the package information. Keep the medication away from children in a tightly closed container, and store it below 30°C (86°F). Accord Healthcare manufactured it and was produced by Intas Pharmaceuticals in India. It must be dispensed for medical prescription with the Medication Guide designed for each patient.*

FDA Label Image

Vilazodone Hydrochloride 40 mg-30 Tablets (Label)

FDA Label Image

Figure 1. Effect Of Other Drugs On Vilazodone Pharmacokinetics (Vilazodone Hydrochloride Figure 1)

This appears to be a partial output from a study on the effects of ethanol and various inhibitors/inducers on CYP3A4 enzyme and proton pump inhibitors. It includes information on fold change and confidence interval. However, without additional context or data, it is difficult to provide a more specific description.*

FDA Label Image

Figure 2. Impact Of Vilazodone On Other Drug Pharmacokinetics (Vilazodone Hydrochloride Figure 2)

This appears to be a list of various substrates and enzymes that affect drug metabolism. It also includes pharmacokinetic measurements such as AUC, CRmp, URmp, CLm, Um, Cmax, and fold change with 90% confidence intervals. The numbers may relate to changes relative to a reference substrate or drug.*

FDA Label Image

Figure 3. Impact Of Intrinsic Factors On Vilazodone Pharmacokinetics (Vilazodone Hydrochloride Figure 3)

FDA Label Image

Vilazodone Hydrochloride Structural Formula (Vilazodone Hydrochloride Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.